Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTIS octreotide for nutritional recovery after esophageal or gastric cancer surgery
2019-001200-38Phase 2Active
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of octreotide in esophageal cancer and gastric cancer (GC) (2 arms), sponsored by Karolinska University Hospital. Started Jan 2020; status: active.
02
Drugs
octreotide
03
Conditions
esophageal cancergastric cancer (GC)
Beyond the preview
Go deeper on 2019-001200-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001200-38.